glp 1 agonists in development GLP-1 Receptor and Research to Treat Overeating and Substance Use Disorders Discovery of GLP-1–Based Drugs for

Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impacton thyroid volume, thyroid function, and autoimmune activity

GLP-1 patches contain no GLP-1 drugs

Read or listen now!

Agents such as dulaglutide, liraglutide, semaglutide, and tirzepatide differ in pharmacology and dosing, directly influencing perioperative safety, particularly due to their effects on gastric motility and the high frequency of gastrointestinal (GI) adverse events that raise concerns about aspiration and postoperative morbidity in urgent or elective procedures

Key Mechanisms of Action : GLP-1 Receptor Agonism (Activation): Similar to current weight-loss drugs, it mimics the GLP-1 hormone to increase satiety (feeling full) and reduce appetite